Harvard Bioscience amends CEO pay, appoints Frost as CFO with $375k base

HARVARD BIOSCIENCE INC

CEO John Duke gets base salary $515k; $100k cash bonus tied to credit facility refinancing.
CEO eligible for annual cash incentive up to 80% of base; target 75k RSUs post 1:10 reverse split.
CFO Mark Frost appointed effective March 6, 2026; salary $375k, annual cash incentive up to 60%.
Frost's target equity grant for 2026 is 30k RSUs post reverse split; agreements run through 2027.
Reverse stock split (1:10) takes effect March 13, 2026 as previously announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.